Coast Guard gets naloxone mandate; Congress demands overdose data

What it does

This bill directs the Coast Guard to update its policy on naloxone (Narcan) and similar overdose-reversal medications, requiring these drugs be available at all Coast Guard installations and in operational environments. It also mandates the Coast Guard join a Defense Department tracking system for overdose incidents and report to Congress within two years on naloxone use, fentanyl prevalence, and substance-abuse mitigation efforts among Coast Guard personnel.

Why we flagged it

The bill's operative mechanism is a mandate to expand naloxone availability and reporting within the Coast Guard, framed as a public-health and personnel-safety measure. The opening amendments to maritime drug-trafficking statutes are technical clarifications, not the bill's primary purpose.

What the text implies

• Mandatory participation in a DoD tracking system may create a permanent database of Coast Guard personnel overdose incidents, potentially affecting career advancement, security clearances, or medical discharge decisions if not carefully protected by privacy safeguards.
• The bill requires naloxone availability 'in each operational environment,' which may impose logistical and cost burdens on remote or maritime operations where supply chains are constrained.
• Reporting requirements to Congress on 'prevalence and incidence of illegal use of fentanyl' may incentivize increased internal surveillance or drug testing of Coast Guard personnel, with unclear consequences for those who seek help.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands access to life-saving overdose-reversal medication for Coast Guard members and personnel, addressing a documented public-health crisis. It increases transparency through mandatory reporting to Congress and does not restrict any citizen rights or protections.

Who stands to gain

• pharmaceutical manufacturers of naloxone and opioid-reversal medications (Amphastar, Adapt Pharma/Pu

Named in the bill

Coast Guard, Department of Defense, National Defense Authorization Act for Fiscal Year 2024, Section 706 tracking system, House Committee on Transportation and Infrastructure, Senate Committee on Commerce, Science, and Transportation, naloxone, fentanyl, Privacy Act (5 U.S.C. 552a), HIPAA (42 U.S.C. 1320d–2)

Where it stands

2 cosponsors: 1 Democrats, 1 Republicans.

• Mar 26, 2025 — Introduced · Congress.gov: “Introduced in House”
• Mar 26, 2025 — Referred to House Committee on Transportation and Infrastructure and Senate Committee on Commerce, Science, and Transportation · Congress.gov: “Referred to the House Committee on Transportation and Infrastructure”
• Apr 2, 2025 — Markup held in committee · Congress.gov: “Committee Consideration and Mark-up Session Held”
• Apr 2, 2025 — Reported out of committee · Congress.gov: “Ordered to be Reported by Voice Vote”
• Jun 9, 2025 — Passed the House · Congress.gov: “On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2547-2548)”
• Jun 9, 2025 — Floor vote scheduled · Congress.gov: “Mr. Ezell moved to suspend the rules and pass the bill”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.